基本信息
views: 57
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Steve Webb is a Senior Staff Specialist in Intensive Care Medicine at Royal Perth Hospital and a Professor of Critical Care Research in the School of Public Health and Preventive Medicine at Monash University. He also holds adjunct Professorial appointments at the University of Western Australia and the George Institute for Global Health.
Dr Webb is a trialist who designs and conducts clinical trials that provide definitive guidance on optimal management for patients with various forms of critical illness. He is a recipient of more than $80M in research funding and has published more than 140 original journal articles including manuscripts in the NEJM (4), JAMA (1), Lancet (2), and BMJ (1).
He is a past-Chair of the ANZICS Clinical Trials Group. He is the Vice-Chair of the International Forum of Acute Care Trialists and a member of the Executive of the International Severe Acute Respiratory Illness Consortium. He is a founding Director of the Australian Clinical Trials Alliance, a foundation Fellow and a member of Council of the Australian Academy of Health and Medical Sciences, and a member of the NHMRC Health Translation Advisory Committee.
His clinical research interests include pandemic preparedness, pneumonia, the long-term consequences of and recovery after critical illness, resuscitation and treatment of patients with septic shock, management of traumatic brain injury, pathogenesis of septic shock, antimicrobial therapy, acute kidney injury, sedation and prevention of delirium, and choice of intravenous fluids in critically ill patients. He is a lead investigator of SPRINT-SARI (Short Period Incidence Study of Severe Acute Respiratory Infection) and REMAP-CAP (Randomised, Embedded, Multifactorial, Adaptive, Platform Trial of Community Acquired Pneumonia) He has particular interest in novel and more efficient trial methods including Platform Trials using Bayesian statistical methods and cluster-crossover trials as well as the interface between clinical trials and healthcare policy.
Dr Webb is a trialist who designs and conducts clinical trials that provide definitive guidance on optimal management for patients with various forms of critical illness. He is a recipient of more than $80M in research funding and has published more than 140 original journal articles including manuscripts in the NEJM (4), JAMA (1), Lancet (2), and BMJ (1).
He is a past-Chair of the ANZICS Clinical Trials Group. He is the Vice-Chair of the International Forum of Acute Care Trialists and a member of the Executive of the International Severe Acute Respiratory Illness Consortium. He is a founding Director of the Australian Clinical Trials Alliance, a foundation Fellow and a member of Council of the Australian Academy of Health and Medical Sciences, and a member of the NHMRC Health Translation Advisory Committee.
His clinical research interests include pandemic preparedness, pneumonia, the long-term consequences of and recovery after critical illness, resuscitation and treatment of patients with septic shock, management of traumatic brain injury, pathogenesis of septic shock, antimicrobial therapy, acute kidney injury, sedation and prevention of delirium, and choice of intravenous fluids in critically ill patients. He is a lead investigator of SPRINT-SARI (Short Period Incidence Study of Severe Acute Respiratory Infection) and REMAP-CAP (Randomised, Embedded, Multifactorial, Adaptive, Platform Trial of Community Acquired Pneumonia) He has particular interest in novel and more efficient trial methods including Platform Trials using Bayesian statistical methods and cluster-crossover trials as well as the interface between clinical trials and healthcare policy.
Research Interests
Papers共 344 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rachael L. Parke,Shay P. McGuinness,Alana Cavadino, Keri-Anne Cowdrey, Samantha Bates, Shailesh Bihari, Amanda Corley,Eileen Gilder,Carol Hodgson, Edward Litton,Colin McArthur,Alistair Nichol,
C40. ARDS AND ACUTE RESPIRATORY FAILURE: MECHANISM, RISK, AND OUTCOMES (2024)
American journal of respiratory and critical care medicine (2024)
American journal of respiratory and critical care medicineno. 5 (2024): 491-496
Computational toxicology (2024): 100292-100292
Trialsno. 1 (2023): 1-15
Health science reportsno. 6 (2023): n/a-n/a
Toxicology Letters (2023): S32-S33
JAMA network openno. 6 (2023): e2317838-e2317838
Trialsno. 1 (2023): 1-15
Load More
Author Statistics
#Papers: 348
#Citation: 23267
H-Index: 66
G-Index: 146
Sociability: 8
Diversity: 4
Activity: 149
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn